Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality

Pancreatic Adenocarcinoma, Version 2.2014

(2017) Margaret A. Tempero et al.   Journal of the National Comprehensive Cancer Network

Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma

(2016) Jordan M. Cloyd et al.   CANCER

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

(2016) Alok A. Khorana et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Radiotherapy: A Risk Factor for Short-Term Wound Complications after Radical Resection for Rectal Cancer?

(2016) Stefan D. Holubar et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy

(2016) Matthew T. McMillan et al.   SURGERY

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma

(2015) Eric A. Mellon et al.   ACTA ONCOLOGICA

Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy

(2015) Lilian Schwarz et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant Radiation Therapy Prior to Total Mesorectal Excision for Rectal Cancer is Not Associated with Postoperative Complications Using Current Techniques

(2014) Sarah A. Milgrom et al.   ANNALS OF SURGICAL ONCOLOGY

The 90-Day Mortality After Pancreatectomy for Cancer Is Double the 30-Day Mortality: More than 20,000 Resections From the National Cancer Data Base

(2014) Richard S. Swanson et al.   ANNALS OF SURGICAL ONCOLOGY

Randomized clinical trial of pancreaticogastrostomyversuspancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy

(2014) J. Figueras et al.   BRITISH JOURNAL OF SURGERY

Preoperative chemoradiation therapy for esophageal cancer is a risk factor for the elevation of high mobility group box-1, leading to an increase in postoperative severe pulmonary complications

(2014) R. Takahata et al.   DISEASES OF THE ESOPHAGUS

Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?

(2014) Amanda B. Cooper et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Postpancreatectomy Hemorrhage—Incidence, Treatment, and Risk Factors in Over 1,000 Pancreatic Resections

(2014) U. F. Wellner et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: Defining quality for pancreaticoduodenectomy

(2014) Marshall S. Baker et al.   JOURNAL OF SURGICAL ONCOLOGY

Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

(2014) Henriette Golcher et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?

(2013) Kathryn T. Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Understanding Hospital Readmissions After Pancreaticoduodenectomy: Can We Prevent Them?

(2013) Zhi Ven Fong et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306

(2013) Hirofumi Mukai et al.   ONCOLOGY

Does pre‐operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post‐operative morbidity? A case‐matched analysis

(2013) Raphael L.C. Araujo et al.   HPB

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

(2012) Ching-Wei D. Tzeng et al.   ANNALS OF SURGICAL ONCOLOGY

Retroperitoneal Dissection in Patients with Borderline Resectable Pancreatic Cancer: Operative Principles and Techniques

(2012) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

A Prospectively Validated Clinical Risk Score Accurately Predicts Pancreatic Fistula after Pancreatoduodenectomy

(2012) Mark P. Callery et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Toward defining grade C pancreatic fistula following pancreaticoduodenectomy: incidence, risk factors, management and outcome

(2012) Jason W. Denbo et al.   HPB

Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

(2011) Matthew H. G. Katz et al.   JOURNAL OF GASTROINTESTINAL SURGERY

A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer

(2011) Jerome Martin Laurence et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma

(2011) Hidenori Takahashi et al.   SURGERY

Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration

(2010) Francesco Polistina et al.   ANNALS OF SURGICAL ONCOLOGY

Risk Stratification for Distal Pancreatectomy Utilizing ACS-NSQIP: Preoperative Factors Predict Morbidity and Mortality

(2010) Kaitlyn Jane Kelly et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

(2009) Ross A. Abrams et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS